Guided Therapeutics, Inc. to Present at Sidoti & Company, LLC 2013 Micro-Cap Conference on Monday, January 7

Guided Therapeutics, Inc., (OTCBB: GTHP) (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease that leads to cancer, today announced that Mark L. Faupel, Ph.D., President and CEO, is scheduled to present a corporate overview at Sidoti & Company’s (www.sidoti.com) 2013 Micro-Cap Conference on Monday, January 7, 2013 at The Grand Hyatt Hotel in New York City.